Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dhaivat Pandya
AddedMar 31, 2024
UpdatedMay 31, 2026
Dhaivat Pandya

Dhaivat Pandya

Founder, JetLenses

CrunchbaseLinkedIn

Dhaivat Pandya's Career

JetLenses
JetLenses

Ahmedabad, Gujarat, IN

Founder
Verse Medical
Verse Medical

New York City, NY, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dhaivat Pandya's Career

JetLenses
JetLenses
52018Ahmedabad, Gujarat, IN
Founder

Similar to JetLenses

Hubble ContactsHubble ContactsNew York City, NY, USContact Lenses, Eyeglassesest. 2016Hubble ContactsNew York City, NY, US · est. 2016

Hubble: Direct-to-consumer, subscription-based contact lens brand.

$78.7M80
LensQuoteLensQuoteBluffton, IN, USContact Lens Softwareest. 2017LensQuoteBluffton, IN, US · est. 2017

LensQuote: Streamlining in-office contact lens sales with innovative software.

$80k3
LensablLensablCulver City, CA, USContact Lenses, Lens Replacementest. 2015LensablCulver City, CA, US · est. 2015

Lensabl: An online retailer offering prescription lenses, designer frames, and lens replacements in California.

$7.3M20
EveryDay ContactsEveryDay ContactsAlbuquerque, NM, USContact Lensesest. 2019EveryDay ContactsAlbuquerque, NM, US · est. 2019

Everyday Contacts: Premium daily disposable lenses promoting eye health with unique wettability technology.

$2.4M3
Verse Medical
Verse Medical
Series Unknown$120k322018New York City, NY, US
Founder

Similar to Verse Medical

Gradia HealthGradia HealthPalo Alto, CA, USHealthcare Platformest. 2021Gradia HealthPalo Alto, CA, US · est. 2021

Gradia: Streamlining patient care & clinic revenue with our healthcare platform.

Seed · $4.3M6
Smartcare SoftwareSmartcare SoftwareEau Claire, WI, USHome Healthcare, Softwareest. 2017Smartcare SoftwareEau Claire, WI, US · est. 2017

SMARTcare Software: Leading enterprise solution for home healthcare automation, optimizing processes for improved profitability.

$5M34
Tomorrow HealthTomorrow HealthNew York City, NY, USHome Healthcareest. 2018Tomorrow HealthNew York City, NY, US · est. 2018

Tomorrow Health: Revolutionizing home healthcare through advanced technology.

$92.5M116
Medically HomeMedically HomeBoston, MA, USMedical Careest. 2016Medically HomeBoston, MA, US · est. 2016

Medically Home: Tech-enabled clinical enterprise shifting hospital care to patients' homes.

$274.5M365

People Similar to Dhaivat Pandya

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoJB LEEJB LEECo-Founder · KakaoDhaivat PandyaDhaivat PandyaCEO, Verse Medical.Laura AshLaura AshFounder · VerseSeyed MadaeniSeyed MadaeniCo-Founder · VerseJason PesterfieldJason PesterfieldBoard Member · LumedaDavid TalDavid TalCo-Founder · VerseAvi TalAvi TalCo-Founder · Verse